Clinical Trials Listing Service

COVID-19 Treatment Outpatient

Last updated: August 6, 2021
Sponsor: N/A
Overall Status: Active - Recruiting

Phase

N/A

Condition

Covid-19

Treatment

N/A

Clinical Study ID

TX279288
  • Ages 18-100
  • All Genders

Study Summary

People with COVID-19 are asked to participate in a research study being conducted by Montefiore Medical Center.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Are a male or female at least 18 years of age
  • Have symptomatic, diagnostically confirmed COVID-19
  • Have either become symptomatic or found positive by RT-PCR
  • Have at least two symptoms of at least moderate severity
  • Have acceptable hematologic status

Exclusion

Exclusion Criteria:

  • Are in need of acute hospitalization
  • Have receiving, has received within the past 7 days or is expected to receive during the course of the study remdesivir, chloroquine, hydroxychloroquine, azithromycin or other specific antiviral therapy
  • Are currently taking or is expected to start taking warfarin, apixabain
  • (Eliquis), argatroban, or rivaroxaban (Xarelto)
  • Are pregnant or breastfeeding

Study Design

Study Start date:
August 06, 2021
Estimated Completion Date:

Study Description

People with COVID-19 are asked to participate in a research study being conducted by Montefiore Medical Center.

Connect with a study center

  • Biomedical Research Alliance of New York LLC

    Bronx, New York 10467
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.